This article, titled “Cost-of-Illness Studies in the United States: A Systematic Review of Methodologies Used for Direct Cost,” published in Value in Health, provides a critical examination of the methods employed in Cost-of-Illness (COI) research in the United States. Authored by Gerd Clabaugh and Marcia M. Ward from the Department of Health Management and Policy at the University of Iowa, this systematic review addresses the growing reliance on COI studies by researchers and policymakers to describe healthcare spending and populate cost-effectiveness models.
The study’s primary objectives were to systematically review COI studies published between 2000 and 2004 to categorize the approaches used in terms of perspective, scope, components of care analyzed, data sets, and direct cost valuation methods. The authors also aimed to assess the adequacy of current COI research methodologies and provide recommendations for improvement.
Utilizing the HealthSTAR online bibliographic information service (which incorporates MEDLINE) with “cost of illness” as a MeSH term, the review initially identified 650 articles. After a rigorous abstract review, 170 articles were selected for detailed examination, ultimately resulting in 52 articles that met all criteria for COI studies. A key inclusion criterion was that studies had to include cost estimates for at least two components of direct medical costs, with a specific focus on direct costs.
Key findings reveal significant methodological limitations and varied approaches across COI studies. The review identified 218 components of care analyzed across the 52 articles, averaging four components per article. The most frequently analyzed components included outpatient care, hospitalization, and prescription medication. Private-insurance or employer-claims data sets were the predominant sources for both utilization and cost information. While nearly half of the studies adopted a societal perspective, a substantial portion represented employer or insurance-based healthcare viewpoints. A notable 85% of the reviewed articles utilized a prevalence approach for their cost calculations.
Despite the utility of COI studies in communicating the relative importance of diseases and injuries to the public and policymakers, the research highlights a concerning lack of breadth in many studies, often underestimating the full cost of illness by focusing on only a few components of care. A frequent omission was the lack of clarity regarding what constituted “cost” (e.g., provider charges versus actual reimbursed amounts). The use of proprietary data sources further poses challenges for replication and generalizability.
In light of these limitations, the authors emphasize the critical need for well-accepted standards to guide researchers. They recommend several key areas for standardization, including the clear disclosure of perspectives, inclusion of all affected components of care, detailed identification of analyzed components, transparent description of data sources (with a preference for publicly available data), ensuring sufficient case numbers for stable estimates, explicit identification of cost types captured, and disclosure of the year reflected in utilization and valuation data. Ultimately, standardizing methods is crucial for policymakers and the public to better understand healthcare investments and inform decisions regarding future insurance benefits, disease control efforts, and health improvement programs.
APA Reference: Clabaugh, G., & Ward, M. M. (2007). Cost-of-illness studies in the United States: A systematic review of methodologies used for direct cost. Value in Health, 10(5), 14–21.
